InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,912.00
(
-0.42%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.54
(
-2.74%
)
Bitcoin
57,996.83
(
-4.30%
)
Post# of 20
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

arconway

Send PM Follow Ignore
Followers 0
Posts 190
Boards Moderated 0
Alias Born 06/01/2005

arconway

Re: arconway post# 1

Thursday, 10/20/2005 7:08:12 PM

Thursday, October 20, 2005 7:08:12 PM

Post# of 20
Here is more news:

Genentech Inc. signed a deal with a nonprofit foundation in Burlingame to study the use of its colorectal cancer drug Avastin as a treatment for brain cancer.
The Food and Drug Administration approved Avastin in February 2004 for colorectal cancer treatment. The drug interferes with angiogenesis, or the growth of blood vessels, in tumors. Genentech has been exploring its use for other types of cancer, including kidney, breast and ovarian.

This baby is a profit machine.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up